Bioxytran Inc (BIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,543 | -1,859 | -296 | -1 | -697 |
| Depreciation Amortization | 259 | 185 | 78 | N/A | 28 |
| Accounts receivable | N/A | N/A | N/A | N/A | -10 |
| Other Working Capital | 263 | 121 | 33 | 1 | 200 |
| Other Operating Activity | 922 | 1,122 | 0 | 0 | 437 |
| Operating Cash Flow | $-1,099 | $-431 | $-186 | $0 | $-42 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -10 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -10 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-10 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 264 | 794 | 222 | N/A | N/A |
| Common Stock Issued | 950 | 20 | 0 | N/A | 50 |
| Other Financing Activity | -233 | -250 | 0 | 0 | 0 |
| Financing Cash Flow | $981 | $564 | $222 | $N/A | $50 |
| Beginning Cash Position | 170 | 36 | 0 | N/A | 4 |
| End Cash Position | 42 | 170 | 36 | 0 | 11 |
| Net Cash Flow | $-128 | $133 | $36 | $0 | $8 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,099 | -431 | -186 | 0 | -42 |
| Free Cash Flow | -1,099 | -431 | -186 | 0 | -42 |